Therapeutic area

Immune system disorders – page 89

1 664 clinical trials
562 recruiting
293 conditions
29 countries

Clinical trials in Immune system disorders

1 664 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

1 664 clinical trials

Rheumatoid arthritis

Not recruiting

Study of Tocilizumab Subcutaneous Injection to Evaluate Bone Healing in Adult Patients with Rheumatoid Arthritis

Registered drugNo placebo

Study of Tocilizumab Subcutaneous Injection to Evaluate Bone Healing in Adult Patients with Rheumatoid Arthritis

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Tocilizumab
Sponsor:Centre Hospitalier Universitaire D Orleans

Contact Research Centre

Ocular myasthenia

Not recruiting

Study on the Effectiveness and Safety of Efgartigimod in Adults with Ocular Myasthenia Gravis

Registered drug

Study on the Effectiveness and Safety of Efgartigimod in Adults with Ocular Myasthenia Gravis

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa
Sponsor:Argenx

Contact Research Centre

Crohn's disease

Not recruiting

Study of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease

Investigational

Study of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Hereditary angioedema

Not recruiting

Study on NTLA-2002 for Treating Hereditary Angioedema in Patients: Evaluating the Effects of Ziclumeran and Lonvoguran

Registered drug

Study on NTLA-2002 for Treating Hereditary Angioedema in Patients: Evaluating the Effects of Ziclumeran and Lonvoguran

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lonvoguran
Sponsor:Intellia Therapeutics Inc.

Contact Research Centre

Giant cell arteritis

Not recruiting

Study on the Effectiveness of Tocilizumab, Methylprednisolone, and Prednisone for Patients with Acute Anterior Ischemic Optic Neuropathy in Giant Cell Arteritis

Registered drugNo placebo

Study on the Effectiveness of Tocilizumab, Methylprednisolone, and Prednisone for Patients with Acute Anterior Ischemic Optic Neuropathy in Giant Cell Arteritis

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Prednisone
Sponsor:Centre Hospitalier National D'Ophtalmologie Quinze-Vingts

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

Study on the Safety and Effectiveness of Taladegib for Patients with Idiopathic Pulmonary Fibrosis

Investigational

Study on the Safety and Effectiveness of Taladegib for Patients with Idiopathic Pulmonary Fibrosis

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Taladegib
Sponsor:Endeavor Biomedicines Inc.

Contact Research Centre

HIV infection

Not recruiting

Study of Weekly Oral GS-1720 and GS-4182 for Untreated HIV-1 Patients

Registered drugNo placebo

Study of Weekly Oral GS-1720 and GS-4182 for Untreated HIV-1 Patients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bictegravir
Sponsor:Gilead Sciences Inc.

Contact Research Centre

Primary biliary cholangitis

Not recruiting

Study on the Safety and Effectiveness of Saroglitazar Magnesium for Patients with Primary Biliary Cholangitis

Investigational

Study on the Safety and Effectiveness of Saroglitazar Magnesium for Patients with Primary Biliary Cholangitis

Investigational

Iceland

Participants:18–64 years · 65+ years
Substances:Saroglitazar hemimagnesium
Sponsor:Zydus Therapeutics Inc.

Contact Research Centre

Hereditary angioedema

Not recruiting

Study of Deucrictibant Extended-Release Tablets for Prevention of Hereditary Angioedema Attacks in Adults and Adolescents

Registered drug

Study of Deucrictibant Extended-Release Tablets for Prevention of Hereditary Angioedema Attacks in Adults and Adolescents

Registered drug

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Deucrictibant
Sponsor:Pharvaris Netherlands B.V.

Contact Research Centre

Multiple sclerosis

Not recruiting

Study on Masitinib for Treating Primary or Secondary Progressive Multiple Sclerosis in Patients Without Relapse

Investigational

Study on Masitinib for Treating Primary or Secondary Progressive Multiple Sclerosis in Patients Without Relapse

Investigational

France

Participants:18–64 years · 65+ years
Substances:Masitinib
Sponsor:Ab Science

Contact Research Centre

Asthma

Not recruiting

Study on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment

Registered drug

Study on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Benralizumab
Sponsor:AstraZeneca AB

Contact Research Centre

Multifocal motor neuropathy

Not recruiting

Study on the Safety and Effects of DNTH103 for Adults with Multifocal Motor Neuropathy

Investigational

Study on the Safety and Effects of DNTH103 for Adults with Multifocal Motor Neuropathy

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:DNTH103
Sponsor:Dianthus Therapeutics Inc.

Contact Research Centre

Substances studied in this area

The therapies tested most often in Immune system disorders trials.

Sodium Chloride61 clinical trials Rituximab50 clinical trials Prednisone47 clinical trials Adalimumab40 clinical trials Emtricitabine40 clinical trials Tenofovir Alafenamide38 clinical trials Tocilizumab38 clinical trials Methotrexate37 clinical trials Prednisolone35 clinical trials

Immune system disorders – page 89

Conditions in this area

Clinical trials in Immune system disorders

1 664 clinical trials

Rheumatoid arthritis

Study of Tocilizumab Subcutaneous Injection to Evaluate Bone Healing in Adult Patients with Rheumatoid Arthritis

Ocular myasthenia

Study on the Effectiveness and Safety of Efgartigimod in Adults with Ocular Myasthenia Gravis

Crohn's disease

Study of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease

Hereditary angioedema

Study on NTLA-2002 for Treating Hereditary Angioedema in Patients: Evaluating the Effects of Ziclumeran and Lonvoguran

Giant cell arteritis

Study on the Effectiveness of Tocilizumab, Methylprednisolone, and Prednisone for Patients with Acute Anterior Ischemic Optic Neuropathy in Giant Cell Arteritis

Idiopathic pulmonary fibrosis

Study on the Safety and Effectiveness of Taladegib for Patients with Idiopathic Pulmonary Fibrosis

HIV infection

Study of Weekly Oral GS-1720 and GS-4182 for Untreated HIV-1 Patients

Primary biliary cholangitis

Study on the Safety and Effectiveness of Saroglitazar Magnesium for Patients with Primary Biliary Cholangitis

Hereditary angioedema

Study of Deucrictibant Extended-Release Tablets for Prevention of Hereditary Angioedema Attacks in Adults and Adolescents

Multiple sclerosis

Study on Masitinib for Treating Primary or Secondary Progressive Multiple Sclerosis in Patients Without Relapse

Asthma

Study on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment

Multifocal motor neuropathy

Study on the Safety and Effects of DNTH103 for Adults with Multifocal Motor Neuropathy

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.